tumor-selective antigens
Pfizer Inks $865M Discovery Deal with Cartography Biosciences for Tumor-Selective Antigens
Pfizer; Cartography Biosciences; pharma deal; tumor-selective antigens; cancer discovery; biotech collaboration
Actionable Insights Powered by AI
Pfizer; Cartography Biosciences; pharma deal; tumor-selective antigens; cancer discovery; biotech collaboration